CD4 and cancer: The most significant DHS enrichments were observed in cell lines derived from blood lymphocytes (e.g. CD4+), skin (e.g. iPS), cancer (e.g. HeLa), embryo (e.g. embryonic stem cells) and in tissues from fetal brain.